CoChat

Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy

Open access
Oberdörster, Günter, Maynard, Andrew, Donaldson, Ken, Castranova, Vincent, Fitzpatrick, Julie, Ausman, Kevin, Carter, Janet, Karn, Barbara, Kreyling, Wolfgang, Lai, David, Olin, Stephen, Monteiro-Riviere, Nancy, Warheit, David, Yang, Hong, A report from the ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group · 2005 · Particle and Fibre Toxicology

The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.

Abstract

The rapid proliferation of many different engineered nanomaterials (defined as materials designed and produced to have structural features with at least one dimension of 100 nanometers or less) presents a dilemma to regulators regarding hazard identification. The International Life Sciences Institute Research Foundation/Risk Science Institute convened an expert working group to develop a screening strategy for the hazard identification of engineered nanomaterials. The working group report presents the elements of a screening strategy rather than a detailed testing protocol. Based on an evaluation of the limited data currently available, the report presents a broad data gathering strategy applicable to this early stage in the development of a risk assessment process for nanomaterials. Oral, dermal, inhalation, and injection routes of exposure are included recognizing that, depending on use patterns, exposure to nanomaterials may occur by any of these routes. The three key elements of the toxicity screening strategy are: Physicochemical Characteristics,In Vitro Assays (cellular and non-cellular), and In Vivo Assays. There is a strong likelihood that biological activity of nanoparticles will depend on physicochemical parameters not routinely considered in toxicity screening studies. Physicochemical properties that may be important in understanding the toxic effects of test materials include particle size and size distribution, agglomeration state, shape, crystal structure, chemical composition, surface area, surface chemistry, surface charge, and porosity. In vitro techniques allow specific biological and mechanistic pathways to be isolated and tested under controlled conditions, in ways that are not feasible in in vivo tests. Tests are suggested for portal-of-entry toxicity for lungs, skin, and the mucosal membranes, and target organ toxicity for endothelium, blood, spleen, liver, nervous system, heart, and kidney. Non-cellular assessment of nanoparticle durability, protein interactions, complement activation, and pro-oxidant activity is also considered. Tier 1 in vivo assays are proposed for pulmonary, oral, skin and injection exposures, and Tier 2 evaluations for pulmonary exposures are also proposed. Tier 1 evaluations include markers of inflammation, oxidant stress, and cell proliferation in portal-of-entry and selected remote organs and tissues. Tier 2 evaluations for pulmonary exposures could include deposition, translocation, and toxicokinetics and biopersistence studies; effects of multiple exposures; potential effects on the reproductive system, placenta, and fetus; alternative animal models; and mechanistic studies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1743-8977-2-8

Cites

171 of 171 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Biokinetics of Nano-sized Particles. While many uptake and translocation routes have been demonstrated, others still are hypothetical and need to be investigated. Largely unknown are translocation rates as well as accumulation and retention in critical target sites and their underlying mechanisms. These as well as potential adverse effects will be largely dependent on physicochemical characteristics of the surface and core of nano-sized particles. Both qualitative and quantitative changes in nano-sized particles' biokinetics in a diseased or compromised organism need also to be considered. Reproduced with permission from Environmental Health Perspectives.
Figure 1 Biokinetics of Nano-sized Particles. While many uptake and translocation routes have been demonstrated, others still are hypothetical and need to be investigated. Largely unknown are translocation rates as well as accumulation and retention in critical target sites and their underlying mechanisms. These as well as potential adverse effects will be largely dependent on physicochemical characteristics of the surface and core of nano-sized particles. Both qualitative and quantitative changes in nano-sized particles' biokinetics in a diseased or compromised organism need also to be considered. Reproduced with permission from Environmental Health Perspectives.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 25

  1. Oberdorster G Gelein RM Ferin J Weiss B Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal Toxicol 1995 7 111 124 11541043 · DOI · Paper page
  2. Monteiro-Riviere NA Wang YY Hong SM Inman AO Nemanich RJ Tan J Proteomic analysis of nanooparticle exposure in human keratonicyte cell culture The Toxicologist 2005 84 2183
  3. Cunningham MJ Magnuson SR Falduto MT Gene expression profiling of nanoscale materials using a systems biology approach The Toxicologist 2005 84 9
  4. Shiohara A Hoshino A Hanaki K Suzuki K Yamamoto K On the cyto-toxicity caused by quantum dots Microbiol Immunol 2004 48 669 675 15383704 · DOI · Paper page
  5. Oberdorster G Gelein RM Ferin J Weiss B Association of particulate air pollution and acute mortality: involvement of ultrafine particles? Inhal Toxicol 1995 7 111 124 11541043 · DOI · Paper page
  6. Oberdorster G Oberdorster E Oberdorster J Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles Environ Health Perspect 2005 113 823 839 16002369 PMC1257642 · DOI · Paper page
  7. Warheit DB Laurence BR Reed KL Roach DH Reynolds GA Webb TR Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats Toxicol Sci 2004 77 117 125 14514968 10.1093/toxsci/kfg228 · DOI · Paper page
  8. Shvedova AA Castranova V Kisin ER Schwegler-Berry D Murray AR Gandelsman VZ Exposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cells J Toxicol Environ Health A 2003 66 1909 1926 14514433 · DOI · Paper page
  9. Cheng Y-S Baron P, Willeke K Condensation Detection and Diffusion Size Seperation Techniques Aerosol Measurement Principles, Techniques and Applications 2001 New York: John Wiley and Sons 569 601
  10. Flagan R Baron P, Willeke K Electrical Techniques Aerosol Measurement: Principles, Techniques and Applications 2001 New York: John Wiley and Sons 537 568
  11. National Institute of Health Guidance Document on Using In Vitro Data to Estimate In Vivo Starting Doses for Acute Toxicity 2001
  12. Kubilus J Cannon CL Klausner M Lonardo EC Human tissue model for vaginal irritation studies The Toxicologist 2002 66 378
  13. Kubilus J Breyfogle B Sheasgreen J Hayden P Wertz P Dale B Characterization of New Buccal and Gingival Epithelial Tissue MatTek Corporation web page 2004 1 2
  14. Worth AP Balls M Alternative (non-animal) methods for chemicals testing: current status and future prospects 2002 71 82
  15. Barlow PG Donaldson K Maccallum J Clouter A Stone V Serum exposed to nanoparticle carbon black displays increased potential to induce macrophage migration Toxicol Lett 2005 155 397 401 15649623 10.1016/j.toxlet.2004.11.006 · DOI · Paper page
  16. Brown DM Wilson MR MacNee W Stone V Donaldson K Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines Toxicol Appl Pharmacol 2001 175 191 199 11559017 10.1006/taap.2001.9240 · DOI · Paper page
  17. Kim H Liu X Kobayashi T Kohyama T Wen FQ Romberger DJ Ultrafine carbon black particles inhibit human lung fibroblast-mediated collagen gel contraction Am J Respir Cell Mol Biol 2003 28 111 121 12495939 10.1165/rcmb.4796 · DOI · Paper page
  18. Brown DM Donaldson K Borm PJ Schins RP Dehnhardt M Gilmour P Calcium and ROS-mediated activation of transcription factors and TNF-alpha cytokine gene expression in macrophages exposed to ultrafine particles Am J Physiol Lung Cell Mol Physiol 2004 286 L344 L353 14555462 10.1152/ajplung.00139.2003 · DOI · Paper page
  19. Schins RP Knaapen AM Cakmak GD Shi T Weishaupt C Borm PJ Oxidant-induced DNA damage by quartz in alveolar epithelial cells Mutat Res 2002 517 77 86 12034310 · DOI
  20. McNeilly JD Heal MR Beverland IJ Howe A Gibson MD Hibbs LR Soluble transition metals cause the pro-inflammatory effects of welding fumes in vitro Toxicol Appl Pharmacol 2004 196 95 107 15050411 10.1016/j.taap.2003.11.021 · DOI
  21. Schins RP Knaapen AM Cakmak GD Shi T Weishaupt C Borm PJ Oxidant-induced DNA damage by quartz in alveolar epithelial cells Mutat Res 2002 517 77 86 12034310 · DOI
  22. Oberdorster G Pulmonary effects of inhaled ultrafine particles Int Arch Occup Environ Health 2001 74 1 8 11196075 10.1007/s004200000185 · DOI · Paper page
  23. Asgharian B Miller FJ, Subramaniam RP Dosimetry software to predict particle deposition in humans and rats 1999
  24. U.S.Environmental Protection Agency Health Effects Test Guidelines OPPTS 8702500 Acute Dermal Irritation 1998
  25. U.S.Environmental Protection Agency Health Effects Test Guidelines OPPTS 8701200 Acute Dermal Toxicity 1998

Cited by

See all 2,134

Metadata

Authors
Oberdörster, G., Maynard, A., Donaldson, K., Castranova, V., Fitzpatrick, J., Ausman, K., Carter, J., Karn, B., Kreyling, W., Lai, D., Olin, S., Monteiro-Riviere, N., Warheit, D., Yang, H., & A report from the ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group
Affiliations
  • University of Rochester Medicine (US)
  • Woodrow Wilson International Center for Scholars (US)
  • Centre for Inflammation Research (GB)
  • National Institute for Occupational Safety and Health (US)
  • International Life Sciences Institute (US)
  • Rice University (US)
  • Procter & Gamble (United States) (US)
  • Environmental Protection Agency (US)
  • Helmholtz Munich (DE)
  • North Carolina State University (US)
  • DuPont (United States) (US)
  • University of Rochester (US)
Corresponding author
Fitzpatrick, Julie
Venue
Particle and Fibre Toxicology
Published
2005-10-06
Volume
2
Issue
1
Pages
8-8
ISSN
1743-8977 (ISSN-L)
OpenAlex
W2140720810
Cited by
2,134
References
171
Citations by year
2026: 28 · 2025: 45 · 2024: 63 · 2023: 59 · 2022: 82 · 2021: 96 · 2020: 94 · 2019: 92 · 2018: 99 · 2017: 115 · 2016: 132 · 2015: 127 · 2014: 160 · 2013: 129 · 2012: 164
FWCI
47.90
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Particle and Fibre Toxicology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • NCSU Libraries Repository (North Carolina State University Libraries) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Site cant be reached (submittedVersion, cc-by)
  • Rice Research Repository (Rice University) (submittedVersion, cc-by)
Funders
  • U.S. Environmental Protection Agency
  • Woodrow Wilson International Center for Scholars
  • Pew Charitable Trusts
  • International Life Sciences Institute Research Foundation
Topics
  • Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
Keywords
engineered nanomaterials, hazard identification, human health risk assessment, in vitro assay, in vivo assay, exposure pathways, pulmonary exposure, dermal exposure, oral exposure, target organ toxicity, complement activation, pro-oxidant activity, toxicokinetics, biopersistence, inflammatory markers, oxidative stress, reproductive toxicity, alternative animal models

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.